Literature DB >> 23764351

Identification and analysis of Crimean-Congo hemorrhagic fever virus from human sera in Tajikistan.

Barry Atkinson1, John Chamberlain, Lisa J Jameson, Christopher H Logue, James Lewis, Evgeniya A Belobrova, Matlyuba Valikhodzhaeva, Manija Mullojonova, Farida H Tishkova, Roger Hewson.   

Abstract

BACKGROUND: Crimean-Congo hemorrhagic fever (CCHF) is a virulent tick-borne disease reported in more than 30 countries across Europe, Africa, and Asia. The disease is considered endemic in several Central Asian countries, including Tajikistan; however reports of human cases from these regions rarely reach the West.
METHODS: We analyzed all historical confirmed cases of CCHF in Tajikistan, mapping these reports against geographic data to assess risk areas. In addition, comprehensive analysis was undertaken on the 2010 human CCHF cohort to demonstrate effective methodologies for diagnosing this disease in-country.
RESULTS: These data show that CCHF is endemic in Tajikistan, and several large clusters have been recorded. Endemic foci of disease are localized to the southern region, with geographical factors such as altitude, monthly mean temperature, and monthly mean precipitation levels limiting establishment of tick vectors in other areas. Genomic analysis of viral RNA from a 2010 human case revealed high nucleotide homology (99%) to a strain isolated in Tajikistan in 1990.
CONCLUSIONS: CCHF is an important vector-borne and nosocomial pathogen in Tajikistan. The ability to rapidly detect cases using real-time RT-PCR shortly after admission in the hospital setting allows prompt implementation of barrier nursing techniques, therefore reducing onward transmission of the virus. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CCHF; Central Asia; Crimean-Congo hemorrhagic fever; Tajikistan

Mesh:

Substances:

Year:  2013        PMID: 23764351     DOI: 10.1016/j.ijid.2013.04.008

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  Sequence Optimized Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Jeffrey W Koehler; Korey L Delp; Adrienne T Hall; Scott P Olschner; Brian J Kearney; Aura R Garrison; Louis A Altamura; Cynthia A Rossi; Timothy D Minogue
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

2.  Spatial cluster analysis of human cases of Crimean Congo hemorrhagic fever reported in Pakistan.

Authors:  Tariq Abbas; Muhammad Younus; Sayyad Aun Muhammad
Journal:  Infect Dis Poverty       Date:  2015-03-02       Impact factor: 4.520

3.  Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of Borno State, Northeastern Nigeria.

Authors:  David N Bukbuk; Stuart D Dowall; Kuiama Lewandowski; Andrew Bosworth; Saka S Baba; Anitha Varghese; Robert J Watson; Andrew Bell; Barry Atkinson; Roger Hewson
Journal:  PLoS Negl Trop Dis       Date:  2016-12-07

4.  Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in Oman.

Authors:  Seif S Al-Abri; Roger Hewson; Hanan Al-Kindi; Idris Al-Abaidani; Amina Al-Jardani; Amal Al-Maani; Samira Almahrouqi; Barry Atkinson; Adil Al-Wahaibi; Bader Al-Rawahi; Shyam Bawikar; Nicholas J Beeching
Journal:  PLoS Negl Trop Dis       Date:  2019-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.